You just read:

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Key Players are Roche, BMS, Sanofi, GSK, Boehringer Ingelheim, Celgene, Novartis and Pfizer

News provided by

Research and Markets

Jul 09, 2015, 11:50 ET